Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amiloride, Riluzole, and Fluoxetine in SPMS
NCT01910259Phase 2Completed
- Sponsor
- University College London
- Start
- Dec 2014
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of amiloride, riluzole, fluoxetine in secondary-progressive multiple sclerosis (SPMS), sponsored by University College London. Started Dec 2014; status: completed.
02
Drugs
amilorideriluzolefluoxetine
03
Conditions
secondary-progressive multiple sclerosis (SPMS)
Beyond the preview
Go deeper on NCT01910259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01910259.